NCT02748369View on ClinicalTrials.gov

In Vivo Assessment of Cellular Metabolism in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

March 2, 2017

Study Completion Date

March 2, 2017

Conditions
Normal Cellular Metabolism
Interventions
DRUG

Somatostatin

Somatostatin infusion to create a low insulin state.

DRUG

Glucagon

Glucagon infusion in the setting of ongoing somatostatin.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

K. Sreekumaran Nair

OTHER

NCT02748369 - In Vivo Assessment of Cellular Metabolism in Humans | Biotech Hunter | Biotech Hunter